Lutiderm

Quick links to important sections

Lutiderm

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lutiderm

Quick Facts

  • Active Ingredient: Fluticasone Propionate
  • Drug Class: Topical Corticosteroid
  • Primary Use: Management of inflammatory skin conditions (e.g., eczema, psoriasis)

Lutiderm is a medication used in dermatology, typically available as a cream or ointment, whose active ingredient is Fluticasone Propionate (a synthetic corticosteroid). As a topical corticosteroid, it is classified as a medium-to-high potency drug and is intended for external application to the skin.

This medication is primarily prescribed to manage and alleviate the symptoms of various inflammatory skin conditions that are responsive to corticosteroids. These conditions often include:

  • Eczema (Dermatitis): To reduce the associated itching, redness, and swelling.
  • Psoriasis: To help manage patches and scaling.
  • Allergic Contact Dermatitis: To calm the inflammatory reaction caused by contact with an irritant or allergen.

Lutiderm works by acting on cells in the skin to reduce inflammation. It achieves this by inhibiting the production of certain chemical messengers that cause the characteristic swelling, redness, and itching associated with these skin disorders. It is crucial to use this medication only as directed by a healthcare professional, as long-term or extensive use of topical corticosteroids can lead to localized side effects such as skin thinning or systemic effects.

What side effects are possible with Lutiderm?

Possible Side Effects and Safety Information

Lutiderm (fluticasone propionate) is a potent topical corticosteroid. The safety profile is characterized by a low incidence of systemic effects when used appropriately. However, the potential for both local and systemic adverse reactions exists.


Adverse Reactions

Classification Common ( ge 1%) Less Common ( < 1%) and Serious Risks
Application Site Burning/stinging sensation, pruritus (itching), irritation, redness. Folliculitis, increased erythema, skin atrophy, dryness, hypopigmentation, acneiform eruptions, allergic contact dermatitis.
Systemic Not reported in clinical trials at common frequency. Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glycosuria (sugar in urine). These risks increase with long-term use, high doses, or application to large surface areas.

Safety Considerations and Restrictions

Contraindications and Warnings: Lutiderm is contraindicated in patients with a known hypersensitivity to fluticasone propionate or any of its components. It is also not recommended for treating untreated skin infections (e.g., viral, bacterial, fungal), perioral dermatitis, rosacea, or acne vulgaris. It is for external use only; contact with the eyes, mouth, and open wounds must be avoided.

Dose- and Exposure-Related Risks: The risk of systemic adverse effects, particularly HPA axis suppression, is significantly increased when the product is used over large body surface areas, for prolonged durations, or with occlusive dressings (such as tight bandages or diapers). These conditions enhance systemic absorption.

Population-Specific Safety: Children and infants are at a greater risk of systemic toxicity (HPA axis suppression and Cushing's syndrome) due to a higher skin surface area to body mass ratio. Its safety and efficacy have not been established for use in infants under three months of age. Pregnant and breastfeeding individuals should use the medication only if the potential benefit outweighs the potential risk, as determined by a healthcare provider.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with topical corticosteroids like Lutiderm (fluocinonide) is primarily related to excessive systemic absorption, which can occur with prolonged use, application over large body surface areas, or the use of occlusive dressings. This systemic absorption may lead to reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, potentially resulting in clinical glucocorticosteroid insufficiency when the drug is stopped.

Documented Systemic Effects

Manifestations of overdose due to systemic absorption include Cushing's syndrome, hyperglycemia, and glucosuria. Children are considered more susceptible to systemic toxicity, including HPA axis suppression and Cushing syndrome.

Required Action

If signs of HPA axis suppression are noted, the drug should be withdrawn, the frequency of application reduced, or a less potent steroid substituted under medical guidance.

Immediate medical attention is required if the medication is accidentally swallowed. In such cases, contact a poison control center or local emergency services immediately.

Therapeutic Uses of Lutiderm

What Lutiderm Treats: Main Uses and Benefits

Lutiderm (Fluticasone Propionate topical) is generally considered relevant for easing symptoms related to inflammatory or irritative states in the skin, providing supportive relief for a range of conditions.

It is commonly used across conditions characterized by periods of heightened symptoms, notably conditions like Eczema (Atopic Dermatitis) and Psoriasis. It is applied in domains where additional symptomatic support is needed in situations involving inflammatory or irritative processes.

The medication helps address symptom clusters that may become intense or disruptive, such as severe itching (pruritus), noticeable redness, and visible swelling. It is considered relevant in contexts involving acute or unstable symptom patterns, typically when manifestations, such as skin scaling and dermal thickening, lead to temporary functional strain or discomfort.

Applied during phases when symptoms become more noticeable, this use may assist with maintaining a sense of stability and helps ease the overall symptom burden. By providing supportive relief when symptoms interfere with routine activities, it contributes to improved day-to-day comfort during symptomatic periods and assists with maintaining functional stability.


Quick Fact: Relief for Inflammation and Pruritus

Eligibility and Restrictions for Use

Who can and cannot use Lutiderm?

Eligibility for Lutiderm (Fluticasone Propionate topical) is strictly governed by regulatory documentation and patient profile. Use is contraindicated in specific populations to mitigate potential risks, primarily systemic absorption and local side effects.


Eligibility Restrictions

Restriction Category Key Regulatory Limitations
Absolute Contraindications Hypersensitivity to any component; patients with rosacea, perioral dermatitis, or untreated viral skin infections (e.g., herpes simplex, varicella) must not use this medicine.
Age-Related Use is not recommended in children under one year of age. Safety and efficacy for use longer than four weeks have not been established in pediatric patients three months of age and older.
Physiological States Pregnancy (Category C): Use only if the potential benefit justifies the risk to the fetus. Lactation: Advised not to apply to the nipple or areola when breastfeeding.
Conditional Use Caution is warranted in patients with hepatic impairment (liver failure) due to increased risk of systemic exposure. Use on the face, groin, or axillae is restricted.

Eligibility Summary

Regulatory documents establish that while the medicine is allowed for adults and adolescents, its use is prohibited for populations with specific skin comorbidities or hypersensitivity. Furthermore, the higher risk of systemic effect in younger patients restricts use in infants and limits the treatment duration for pediatric patients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Interaction Profile

The officially documented interaction profile for Lutiderm (Fluticasone Propionate topical) focuses primarily on the risk of increased systemic exposure, which can occur despite low topical absorption. This risk is managed through specific restrictions outlined in regulatory labeling.

Interaction Classification Interacting Substance/Class Official Regulatory Statement
Pharmacokinetic (Metabolic) Strong CYP3A4 Inhibitors (e.g., Ritonavir, Ketoconazole) Co-administration is not recommended. These substances reduce the drug's clearance, leading to significantly increased systemic exposure (AUC and Cmax) of Fluticasone Propionate.
Pharmacodynamic Other Corticosteroid-Containing Products Use carries an additive risk of systemic corticosteroid effects, increasing the potential for Hypothalamic-Pituitary-Adrenal (HPA) axis suppression.
Drug–Substance Grapefruit Juice Documented as an inhibitor of the CYP3A4 enzyme, capable of increasing systemic exposure.

Population and Contextual Notes

The constraint against co-administration with strong CYP3A4 inhibitors is critical as the systemic exposure increase may lead to clinically significant corticosteroid effects. This risk is formally noted to be heightened in populations with hepatic impairment, where the drug’s clearance is already reduced. The regulatory documentation strictly focuses on these pharmacokinetic, pharmacodynamic, and population-specific restrictions.

Mechanism of Action

How Lutiderm Works: Pharmacodynamic Mechanism

The mechanism of Fluticasone Propionate involves three interlocking mechanistic domains that modulate fundamental biological processes.

Glucocorticoid Receptor Activation and Genomic Modulation

The drug functions as a selective agonist for the intracellular Glucocorticoid Receptor (GR). The activated complex translocates to the cell nucleus, where it modulates gene expression through transrepression (silencing pro-inflammatory genes) and transactivation (inducing anti-inflammatory proteins). This molecular cascade results in the modulation of the localized immune response, specifically by limiting inflammatory cell proliferation and migration.

Arachidonic Acid Pathway Blockade

The mechanism proceeds by targeting the Arachidonic Acid Cascade. By inducing the protein Lipocortin-1, the drug indirectly inhibits the enzyme Phospholipase A2 (PLA2). This action prevents the formation of downstream mediators like prostaglandins and leukotrienes, contributing to the physiological consequence of reduced capillary permeability and fluid extravasation.

Modulation of Local Vascular Tone

Independent of its genomic effects, the drug directly influences the smooth muscle cells of dermal blood vessels, resulting in local vasoconstriction. This mechanistic domain contributes to the overall physiological changes by reducing local blood flow and altering the systemic response in the dermal capillary beds.

Dosage and Administration Information

How to Use Lutiderm

Lutiderm (Fluticasone Propionate) is administered topically and is intended for external application to the skin only. The medication is available in several official formulations, including a 0.05% cream, a 0.005% ointment, and a 0.05% lotion, all of which require a specific administration schedule.


Administration Protocol

The standard regimen involves applying a thin film of the product to the affected area. This thin film should be rubbed in gently and thoroughly. The dosing frequency is dependent on the specific formulation, with the ointment typically applied twice daily and the lotion or cream often applied once daily or twice daily, as specified by clinical guidelines.


Usage Duration and Restrictions

Therapy should be discontinued when control of the condition is achieved, establishing the treatment goal as the primary endpoint. The safety and efficacy of continuous daily use are generally not established beyond four weeks. If no improvement is observed within two weeks of treatment, official guidelines suggest a reassessment of the diagnosis may be necessary.

Crucially, the official protocol advises against covering the treated skin area with an occlusive dressing or bandage unless specifically directed. Application of Lutiderm is also generally restricted from sensitive areas, such as the face, groin, or underarms.

Recent Clinical Evidence

Research evidence / Overview of Studies for Lutiderm

Research evidence available for Lutiderm (Fluticasone Propionate topical) has been derived primarily from controlled clinical trials, systematic reviews, and meta-analyses. These studies was evaluated in conditions linked to inflammatory or irritative states in the skin. Findings describe group patterns observed in studies and contribute to the broader evidence landscape. Research does not determine whether an individual will respond similarly.


Evidence for use in Atopic Dermatitis (Eczema)

Research exploring Lutiderm was evaluated in studies focusing on conditions characterized by fluctuating or episodic manifestations (Atopic Dermatitis). Studies explored both short-term use during periods of heightened symptoms and regimens designed to monitor stability. The main evidence comes from Randomized Controlled Trials (RCTs) where the medicine was compared against a non-medicated cream, known as a vehicle, in research exploring how symptoms change over time.

Study Focus: Acute Symptom Relief

Studies were conducted during research scenarios focusing on episodes where symptoms become more noticeable. Research examined changes in specific outcomes related to physical discomfort, including measurable signs like redness (erythema) and patient-reported outcomes describing perceived discomfort, like itching (pruritus). Findings describe patterns observed in the studies. Research describes measured changes in the assessed symptoms when compared to the vehicle cream.


Long-Term Studies and Follow-up

The majority of evidence was observed in research exploring short-term symptom changes, typically up to four weeks for the acute application phase. For maintenance regimens, the follow-up durations were limited, extending up to 16 weeks in some trials. Regarding extended outcomes, long-term effects are not fully established, and there is limited information available that tracks the patient's course over extended time intervals.


Evidence in Special Populations

Research has explored the use of the medicine in specific populations, notably Pediatric Patients. Lutiderm was evaluated in children, including infants as young as 3 months, who presented with moderate to severe Atopic Dermatitis. Studies observed these young populations during research exploring short-term symptom changes. Results apply only to the populations studied, and data for certain groups remain insufficient.

Key Studies & References

  1. Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis (Psoriasis Efficacy RCT)

Frequently Asked Questions (FAQ)

Common questions about Lutiderm (FAQ)


Q: Is it true that long-term use of Lutiderm can cause skin thinning?

Regulatory safety information indicates that skin changes are a possible local reaction. Specifically, the medical term skin atrophy, which can result in skin thinning, is listed as a less common effect. The risk of this type of change is described as potentially higher when the medicine is used for prolonged periods or under occlusive dressings.


Q: Can Lutiderm interact with over-the-counter pain relievers?

Official documentation focuses interaction warnings primarily on substances that significantly affect the body's breakdown of the drug, such as strong CYP3A4 inhibitors. A specific warning is issued regarding the additive risk when Lutiderm is used with other corticosteroid-containing products. For all other medications, including common over-the-counter pain relievers, official guidance describes the importance of informing a healthcare provider about all products being used.


Q: Are there any specific foods or drinks to avoid while using Lutiderm?

The only food item explicitly noted in regulatory documents for a strong potential interaction is Grapefruit Juice. Consuming Grapefruit Juice may increase the amount of the drug absorbed into the body, which can increase the risk of systemic effects.


Q: Is Lutiderm safe to use during pregnancy, according to official data?

Regulatory documentation notes that the drug is in Pregnancy Category C. This classification is used when there are no adequate and well-controlled studies conducted in pregnant women. Official sources note that there is a potential risk to the fetus that must be considered.


Q: What is the safety classification of Lutiderm for breastfeeding?

Regulatory documents advise against applying the medicine directly to the nipple or areola area when breastfeeding. Furthermore, the regulatory documents state that it is not known if the drug passes into breast milk or the potential risk to the breastfed child.


Q: How quickly should I expect to see an effect from Lutiderm?

Official patient information suggests a time frame for expected initial response. If no improvement is observed after two weeks of starting treatment, regulatory guidelines indicate that a reassessment of the diagnosis may be necessary.


Q: Does Lutiderm cause changes in skin color?

Regulatory safety information lists hypopigmentation as a possible local adverse reaction. Hypopigmentation is a change that results in the treated skin area becoming lighter in color.


Q: What is the difference between Lutiderm cream and the lotion form?

Official regulatory documents classify the medicine into different formulations, such as a cream or a lotion. These forms have different inactive ingredients, which results in differences in consistency and spreadability. They may also be associated with distinct administration frequencies specified in the labeling.


Q: How long after starting Lutiderm is it considered 'not working'?

Official guidelines indicate a benchmark period to evaluate the medicine's effect. If no improvement is observed within two weeks of starting treatment, regulatory documents suggest that the diagnosis may need to be reassessed.


Q: Does Lutiderm have different strengths or concentrations?

Yes, the medicine is available in various formulations that have different active ingredient concentrations. Examples include a 0.05% cream, a 0.005% ointment, and a 0.05% lotion, each with specific regulatory instructions for use.


Q: Can Lutiderm be stored in the refrigerator?

Official guidelines specify that Lutiderm must be stored at Controlled Room Temperature, which is generally between 20 C and 25 C. The labeling specifies constraints against freezing or exposure to excessive heat or moisture.


Q: How does Lutiderm compare to other common treatments for the same condition?

Lutiderm (fluticasone propionate topical) is a synthetic corticosteroid used to manage inflammatory skin conditions. Official documents classify it as a medium-to-high potency drug within the topical corticosteroid therapeutic class.


Q: What happens if I accidentally use more Lutiderm than suggested?

Using more than the suggested amount increases the risk of the drug being absorbed systemically, leading to potential side effects. Official patient information for this drug class describes that contact with a Poison Control Center or seeking immediate medical help is necessary in the event of an overdose.


Q: Can children or infants use Lutiderm?

Official labeling states that the medicine is not recommended for use in children under one year of age. For pediatric patients aged 3 months and older, its safety and efficacy are not established beyond four weeks of continuous use.


Q: Is there a maximum age limit for using Lutiderm?

Official labeling does not establish a specific maximum age limit for using this medication. It is indicated for use in adult patients, with standard cautions noted for groups such as those with reduced liver function.


Q: What research studies have been done on the long-term safety of Lutiderm?

Official research evidence states that the majority of the data involves short-term use, typically up to four weeks. Consequently, long-term effects are not fully established, and follow-up durations are limited, extending up to 16 weeks in some trials.


Q: Is it normal to feel dizzy or lightheaded after using Lutiderm?

Lightheadedness is listed in regulatory documents as a less common adverse reaction. This means it was reported in less than 1% of patients during controlled clinical trials.


Q: Has Lutiderm been studied in different ethnic groups or skin types?

Regulatory documents only report on studies involving specific groups, such as pediatric patients. The documents do not generally provide a breakdown of evidence across different ethnic groups or skin types.


Q: Do I need to wash my hands immediately after applying Lutiderm?

Regulatory documents describe that hand washing is recommended after applying the medication. This hygiene step is recommended unless the hands themselves are the area being treated with the medicine.


Q: Does Lutiderm require a prescription, or is it available over the counter?

Lutiderm (fluticasone propionate topical) is categorized in the United States as a Human Prescription Drug product.

How should Lutiderm be stored and disposed of?

Storage Requirements

Official regulatory guidelines require Lutiderm (fluticasone propionate ointment) to be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be stored in its original container and kept tightly closed to maintain integrity. Mandatory environmental constraints include protecting the ointment from light and moisture, and a strict prohibition against freezing. All medicine must be kept out of the sight and reach of children and pets.

Disposal Instructions

Disposal of unused or expired Lutiderm must follow local regulations for pharmaceutical waste. The preferred method is to utilize drug take-back programs when available. If disposed of in household trash, the unused ointment should be mixed with an unappealing substance, such as dirt or used coffee grounds, and sealed in a bag. The medicine must not be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lutiderm found in:

A-Z Index: